Literature DB >> 7548539

Antibiotic effects on bacterial viability, toxin production, and host response.

D L Stevens1, A E Bryant, S P Hackett.   

Abstract

The efficacy of an antibiotic in human or experimental infection is presumed to be proportional to its in vitro antimicrobial activity, yet antibiotics having comparable in vitro activity may have markedly different efficacies in vivo. For example, we have reported that clindamycin is more efficacious than penicillin in experimental gas gangrene caused by Clostridium perfringens in animals. To explain these differences, we compared the dynamics of bacterial killing and suppression of toxin synthesis. In addition, we investigated the ability of clindamycin and penicillin to modulate lipopolysaccharide-induced cytokine production in human peripheral blood mononuclear cells. Our results suggest that clindamycin affects protein synthesis in both prokaryotic and eukaryotic cells. These data may, in part, explain why the efficacy of clindamycin is greater than that of penicillin and demonstrate that clindamycin may be important immune modulator.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548539     DOI: 10.1093/clinids/20.supplement_2.s154

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  34 in total

1.  Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system.

Authors:  Arnold Louie; Brian D Vanscoy; Henry S Heine; Weiguo Liu; Terry Abshire; Kari Holman; Robert Kulawy; David L Brown; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

2.  Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes.

Authors:  Jun Sawai; Tadao Hasegawa; Takuya Kamimura; Akira Okamoto; Daisuke Ohmori; Nobuyuki Nosaka; Keiko Yamada; Keizo Torii; Michio Ohta
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

3.  Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis.

Authors:  Megumi Tanaka; Tadao Hasegawa; Akira Okamoto; Keizo Torii; Michio Ohta
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 4.  Necrotising fasciitis: a new management algorithm based on clinical classification.

Authors:  Paul S Carter; Paul E Banwell
Journal:  Int Wound J       Date:  2004-09       Impact factor: 3.315

5.  Wound botulism complicating internal fixation of a complex radial fracture.

Authors:  Steve M Taylor; Cameron R Wolfe; Terry C Dixon; David S Ruch; Gary M Cox
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

6.  Mycotic aneurysm caused by Clostridium septicum in a patient with colorectal cancer.

Authors:  Winesh Ramphal; Niels J Raaijmakers; Marjolein van der Klift; Jan H Wijsman; Jan A J W Kluytmans; Eelco J Veen
Journal:  Infection       Date:  2018-05-29       Impact factor: 3.553

7.  Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.

Authors:  Patrick M Schlievert
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

8.  Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracis.

Authors:  A Louie; H S Heine; K Kim; D L Brown; B VanScoy; W Liu; M Kinzig-Schippers; F Sörgel; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

9.  Necrotizing fasciitis due to Vibrio alginolyticus in an immunocompetent patient.

Authors:  Juan M Gomez; Roosevelt Fajardo; Jose F Patiño; Cesar A Arias
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.

Authors:  Binh An Diep; Anna Afasizheva; Hoan N Le; Osamu Kajikawa; Gustavo Matute-Bello; Christine Tkaczyk; Bret Sellman; Cedric Badiou; Gerard Lina; Henry F Chambers
Journal:  J Infect Dis       Date:  2013-03-26       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.